Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Matthew Caufield is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/19/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/14/2025 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 1112.86% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
03/12/2025 | ZBIO | Buy Now | Zenas BioPharma | $7.90 | 279.75% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
03/10/2025 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
03/10/2025 | UBX | Buy Now | Unity Biotechnology | $1.81 | 341.87% | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
03/07/2025 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/03/2025 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
03/03/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
02/28/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
02/21/2025 | IMUX | Buy Now | Immunic | $1.14 | 777.19% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
02/19/2025 | IRD | Buy Now | Opus Genetics | $1.15 | 596.62% | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
02/13/2025 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
02/13/2025 | FBLG | Buy Now | FibroBiologics | $1.02 | 1076.47% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
02/10/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
02/06/2025 | EYEN | Buy Now | Eyenovia | $1.55 | 29.03% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
01/30/2025 | SRZN | Buy Now | Surrozen | $11.00 | 190.91% | Matthew Caufield37% | → $32 | Initiates | → Buy | Get Alert |
01/29/2025 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
01/13/2025 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
01/03/2025 | OPTN | Buy Now | OptiNose | $5.85 | 207.69% | Matthew Caufield37% | $5 → $18 | Maintains | Buy | Get Alert |
12/16/2024 | ZBIO | Buy Now | Zenas BioPharma | $7.90 | 279.75% | Matthew Caufield37% | → $30 | Initiates | → Buy | Get Alert |
12/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
12/12/2024 | IRD | Buy Now | Opus Genetics | $1.15 | 596.62% | Matthew Caufield37% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
11/25/2024 | IMUX | Buy Now | Immunic | $1.14 | 777.19% | Matthew Caufield37% | → $10 | Initiates | → Buy | Get Alert |
11/19/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
11/18/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 29.03% | Matthew Caufield37% | $960 → $160 | Downgrade | Buy → Neutral | Get Alert |
11/15/2024 | KOD | Buy Now | Kodiak Sciences | $3.24 | -7.41% | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
11/15/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $5.70 | 22.81% | Matthew Caufield37% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
11/14/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | FBLG | Buy Now | FibroBiologics | $1.02 | 1076.47% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
11/13/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
11/12/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
11/07/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 58.33% | Matthew Caufield37% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
10/31/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
10/30/2024 | FBLG | Buy Now | FibroBiologics | $1.02 | 1076.47% | Matthew Caufield37% | → $12 | Initiates | → Buy | Get Alert |
10/10/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $5.70 | 22.81% | Matthew Caufield37% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
10/07/2024 | DMAC | Buy Now | DiaMedica Therapeutics | $5.70 | 22.81% | Matthew Caufield37% | → $7 | Initiates | → Buy | Get Alert |
09/24/2024 | KOD | Buy Now | Kodiak Sciences | $3.24 | -7.41% | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
09/19/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
09/05/2024 | KOD | Buy Now | Kodiak Sciences | $3.24 | -7.41% | Matthew Caufield37% | → $3 | Initiates | → Neutral | Get Alert |
09/03/2024 | OPT | Buy Now | Opthea | $3.31 | 262.54% | Matthew Caufield37% | $14 → $12 | Maintains | Buy | Get Alert |
08/15/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 1112.86% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
08/15/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 58.33% | Matthew Caufield37% | $38 → $38 | Reiterates | Buy → Buy | Get Alert |
08/15/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $20 → $18 | Maintains | Buy | Get Alert |
08/15/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
08/13/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
08/13/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
08/12/2024 | HLVX | Buy Now | HilleVax | $1.72 | 16.28% | Matthew Caufield37% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
08/12/2024 | LENZ | Buy Now | LENZ Therapeutics | $24.00 | 58.33% | Matthew Caufield37% | → $38 | Initiates | → Buy | Get Alert |
08/12/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
08/09/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
08/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
07/24/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
07/19/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
07/10/2024 | MLYS | Buy Now | Mineralys Therapeutics | $15.43 | 94.43% | Matthew Caufield37% | → $30 | Initiates | → Buy | Get Alert |
07/09/2024 | HLVX | Buy Now | HilleVax | $1.72 | — | Matthew Caufield37% | — | Downgrade | Buy → Neutral | Get Alert |
06/07/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
05/15/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | HLVX | Buy Now | HilleVax | $1.72 | 1527.91% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
05/07/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 1112.86% | Matthew Caufield37% | → $2 | Downgrade | Buy → Neutral | Get Alert |
05/06/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
05/01/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
04/30/2024 | ADVM | Buy Now | Adverum Biotechnologies | $5.07 | 491.72% | Matthew Caufield37% | → $30 | Initiates | → Buy | Get Alert |
04/29/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
04/02/2024 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 51.95% | Matthew Caufield37% | → $10 | Reinstates | Buy → Buy | Get Alert |
03/22/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | HLVX | Buy Now | HilleVax | $1.72 | 1527.91% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
03/18/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
03/11/2024 | OPTN | Buy Now | OptiNose | $5.85 | -14.53% | Matthew Caufield37% | → $75 | Initiates | → Buy | Get Alert |
03/08/2024 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | $960 → $960 | Reiterates | Buy → Buy | Get Alert |
03/01/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | $36 → $36 | Reiterates | Buy → Buy | Get Alert |
12/13/2023 | HLVX | Buy Now | HilleVax | $1.72 | 1527.91% | Matthew Caufield37% | → $28 | Initiates | → Buy | Get Alert |
11/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
10/02/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | → $12 | Reiterates | Buy → Buy | Get Alert |
08/31/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.16 | 7177.14% | Matthew Caufield37% | → $12 | Initiates | → Buy | Get Alert |
08/22/2023 | FN | Buy Now | Fabrinet | $222.86 | -87.44% | Matthew Caufield37% | → $28 | Reiterates | Buy → Buy | Get Alert |
08/18/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
08/14/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | → $28 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
08/10/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
08/09/2023 | PHAT | Buy Now | Phathom Pharmaceuticals | $5.78 | 384.5% | Matthew Caufield37% | → $28 | Initiates | → Buy | Get Alert |
08/09/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | Buy → Buy | Get Alert |
08/01/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield37% | → $14 | Reiterates | Buy → Buy | Get Alert |
07/31/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
06/30/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | Buy → Buy | Get Alert |
06/22/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | Buy → Buy | Get Alert |
06/16/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | Buy → Buy | Get Alert |
06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
05/16/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | Buy → Buy | Get Alert |
05/11/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | Buy → Buy | Get Alert |
05/10/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | → Buy | Get Alert |
05/05/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | → Buy | Get Alert |
05/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | $35 → $40 | Downgrade | Buy → Neutral | Get Alert |
04/28/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
04/19/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | → Buy | Get Alert |
04/03/2023 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Reiterates | → Buy | Get Alert |
03/31/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | → Buy | Get Alert |
03/28/2023 | UBX | Buy Now | Unity Biotechnology | $1.81 | 452.33% | Matthew Caufield37% | → $10 | Reiterates | → Buy | Get Alert |
03/16/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
03/10/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | → Buy | Get Alert |
03/02/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | → $35 | Reiterates | → Buy | Get Alert |
03/01/2023 | ALDX | Buy Now | Aldeyra Therapeutics | $6.58 | 127.93% | Matthew Caufield37% | → $15 | Reiterates | → Buy | Get Alert |
02/24/2023 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield37% | → $14 | Reiterates | → Buy | Get Alert |
02/23/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
02/17/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | → $20 | Reiterates | → Buy | Get Alert |
02/17/2023 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | → $35 | Reiterates | → Buy | Get Alert |
02/06/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Reiterates | → Buy | Get Alert |
01/26/2023 | OCUP | Buy Now | Ocuphire Pharma | — | — | Matthew Caufield37% | $26 → $20 | Maintains | Buy | Get Alert |
12/08/2022 | OPT | Buy Now | Opthea | $3.31 | 322.96% | Matthew Caufield37% | → $14 | Initiates | → Buy | Get Alert |
11/18/2022 | FDMT | Buy Now | 4D Molecular Therapeutics | $3.96 | 809.09% | Matthew Caufield37% | → $36 | Initiates | → Buy | Get Alert |
11/04/2022 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | $26 → $35 | Maintains | Buy | Get Alert |
10/05/2022 | EYEN | Buy Now | Eyenovia | $1.55 | 674.19% | Matthew Caufield37% | → $960 | Initiates | → Buy | Get Alert |
07/18/2022 | OYST | Buy Now | Oyster Point Pharma | — | — | Matthew Caufield37% | → $20 | Initiates | → Buy | Get Alert |
11/10/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | $20 → $26 | Maintains | Buy | Get Alert |
08/19/2021 | ISEE | Buy Now | IVERIC bio | — | — | Matthew Caufield37% | → $20 | Initiates | → Buy | Get Alert |